After liver transplant for HCV, better antiviral results with cyclosporine
NEW YORK (Reuters Health) - In patients transplanted for hepatitis C cirrhosis, the virus inevitably
recurs. Now a new meta-analysis suggests that cyclosporine-based immunosuppression may be associated with a better
response to antiviral therapy after transplant than tacrolimus-based protocols. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news
ICD therapy effective in the real-world
NEW YORK (Reuters Health) - Implantable cardioverter-defibrillators (ICDs) work as well in the
real-world as in clinical trials, a new study suggests. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news
Maintenance nifedipine tocolysis doesn't improve perinatal outcomes
NEW YORK (Reuters Health) - Maintenance tocolysis with nifedipine after an initial course of
tocolytics and corticosteroids did not improve perinatal outcomes relative to placebo in the large Dutch APOSTEL-II
trial of women with threatened preterm labor. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news
Surgery not helpful in metastatic neuroblastoma
NEW YORK (Reuters Health) - Primary resection of stage 4 neuroblastoma does not appear to confer any
benefit, German researchers say. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news
UPDATE: After liver transplant for HCV, better antiviral results with cyclosporine
NEW YORK (Reuters Health) - In patients transplanted for hepatitis C cirrhosis, the virus inevitably
recurs. Now a new meta-analysis suggests that cyclosporine-based immunosuppression may be associated with a better
response to antiviral therapy after transplant than tacrolimus-based protocols. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news
UK norovirus cases reach over 1.1 million
LONDON (Reuters) - More than 1.1 million people in Britain have succumbed to norovirus so far this
season, and health officials expect cases to jump higher after a Christmas and New Year dip. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news
Are recession babies prone to be delinquent teens?
NEW YORK (Reuters Health) - A new analysis of data on U.S. teens born during the early 1980s ties
slightly higher rates of adolescent smoking, drinking, arrests and thefts to macroeconomic conditions during the
first year of life. (Source: Modern Medicine)
Source: Modern Medicine - January 2, 2013 Category: Journals (General) Source Type: news
Analysis bolsters expulsive therapy's cost-effectiveness
Patients who receive medical expulsive therapy as initial management for renal colic incur
significantly lower episode-related expenditures than those undergoing early endoscopic stone removal, but are
significantly more likely to have return visits to the emergency department, report researchers from the University
of Michigan, Ann Arbor. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news
Expulsive therapy less costly than surgery for renal colic
Medical expulsive therapy for the initial management of uncomplicated acute renal colic, with eventual
uretereoscopy if needed, is associated with less resource utilization and lower 6-week costs than early surgery,
say researchers from the University of Michigan, Ann Arbor. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news
Like it or not, urology is a business
Sifting through the data that came out of Urology Times' recently released "State of the
Specialty" survey, it's clear that the issues most concerning to urologists relate to the business side of
practicing medicine. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news
Post-cystectomy survival predicted by hospital volume
Hospital volume is a key predictor of survival for patients with urothelial bladder cancer undergoing
radical cystectomy and has a greater impact than surgeon volume, findings from a retrospective analysis
suggest. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news
Which recent drug has had the biggest impact on urology?
Urologists discuss the treatments that have most affected their practices. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news
Study questions botulinum's efficacy in post-BPH overactive bladder
Intradetrusor injections of onabotulinumtoxinA (Botox) do not significantly reduce urinary frequency
in patients with refractory overactive bladder secondary to BPH, results from a two-institution, placebo-controlled
study indicate. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news
Urology Product Preview
Drugs and devices in the pipeline from Auxilium Pharmaceuticals, Inc., Nymox Pharmaceutical Corp.,
Palatin Technologies, Inc., ProUroCare Medical Inc., Bioniche Life Sciences Inc., Tengion Inc., Aeterna Zentaris
Inc., and Can-Fite BioPharma. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news
New Urology Products & Services
The latest products and services from Coloplast, Galt Medical (Theragenics Corp.), the Medical Group
Management Association, SullivanLuallin, Accuray Inc., the Simon Foundation for Continence, Varian Medical Systems,
FAIR Health, Patient Point, UroMed, Cure Medical, and Three Ten LLC. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news
